(Total Views: 57)
Posted On: 07/07/2025 12:21:50 PM
Post# of 38712

$ONCY a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Andrew Aromando as Chief Business Officer.
https://finance.yahoo.com/news/oncolytics-bio...00307.html
https://finance.yahoo.com/news/oncolytics-bio...00307.html

